3,0
24. Apr. 2015
Aktueller Mitarbeiter, mehr als 8 Jahre
Moskau,
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Innovative company, looking for acquisitions, significant investments in emerging markets, many launches of new products, one of them potential blockbuster in oncology that is breakthrough therapy
Kontras
Transformation 3 years in a row, many people left the company, internal initiative on talents doesn't work, prefer hiring outside, competition is not competitive